Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Retractable Technologies | RVP | Sep 27, 2024 | 0.76 | +5.13 |
REV Group | REVG | Sep 27, 2024 | 27.20 | +2.18 |
Revance Therapeutics | RVNC | Sep 27, 2024 | 5.36 | -0.56 |
Revelation Biosciences | REVB | Sep 27, 2024 | 0.89 | +5.77 |
Revenueshares Largecap | RWL | Sep 27, 2024 | 97.87 | +0.40 |
Revenueshares Midcap | RWK | Sep 27, 2024 | 116.50 | +0.27 |
Revenueshares Smallcap | RWJ | Sep 27, 2024 | 45.87 | +1.24 |
Revenueshares Ultra Dividend Fund | RDIV | Sep 27, 2024 | 49.72 | +0.59 |
Reviva Pharmaceuticals | RVPH | Sep 27, 2024 | 1.35 | +0.75 |
Revolution Medicines | RVMD | Sep 27, 2024 | 44.17 | +0.71 |
Revolve Group A | RVLV | Sep 27, 2024 | 24.99 | -1.23 |
Revvity | RVTY | Sep 27, 2024 | 126.06 | -0.22 |
REX American Resources | REX | Sep 27, 2024 | 46.12 | +3.13 |
Rexford Industrial Realty | REXR | Sep 27, 2024 | 50.51 | -0.14 |
Rexford Industrial Realty B Pref | REXR-B | Sep 27, 2024 | 24.33 | +0.66 |
Rexford Industrial Realty C Pref | REXR-C | Sep 27, 2024 | 23.90 | +0.04 |
Reynolds Consumer Products | REYN | Sep 27, 2024 | 31.14 | +0.61 |
Rezolute | RZLT | Sep 27, 2024 | 4.98 | +2.05 |
Rezolve AI Limited - Ordinary Shares | RZLV | Sep 27, 2024 | 7.38 | 0.00 |
RF Acquisition A | RFAC | Sep 27, 2024 | 11.24 | 0.00 |
RF Acquisition Corp II | RFAIU | Sep 27, 2024 | 10.40 | 0.00 |
RF Acquisition II | RFAI | Sep 27, 2024 | 10.12 | 0.00 |
RF Industries | RFIL | Sep 27, 2024 | 3.74 | +1.08 |
RGC Resources | RGCO | Sep 27, 2024 | 22.67 | +6.18 |
RH | RH | Sep 27, 2024 | 339.50 | -0.06 |
Rhinebeck Bancorp | RBKB | Sep 27, 2024 | 9.25 | -1.28 |
Rhythm Pharmaceuticals | RYTM | Sep 27, 2024 | 51.35 | +0.43 |
Ribbon Communications | RBBN | Sep 27, 2024 | 3.26 | +0.93 |
Richardson Electronics | RELL | Sep 27, 2024 | 12.41 | +2.82 |
Richmond Mutual Bank | RMBI | Sep 27, 2024 | 12.89 | +0.16 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.